Everence Capital Management Inc. Cuts Position in Henry Schein, Inc. (NASDAQ:HSIC)

Everence Capital Management Inc. reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 30.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,830 shares of the company’s stock after selling 1,670 shares during the period. Everence Capital Management Inc.’s holdings in Henry Schein were worth $265,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Cromwell Holdings LLC grew its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares during the period. Versant Capital Management Inc increased its position in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares in the last quarter. Farther Finance Advisors LLC raised its position in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in Henry Schein during the third quarter worth approximately $109,000. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of HSIC stock opened at $71.67 on Wednesday. The stock’s 50-day moving average price is $72.13 and its 200 day moving average price is $70.37. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The stock has a market capitalization of $8.94 billion, a PE ratio of 29.49, a price-to-earnings-growth ratio of 2.30 and a beta of 0.89. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the firm posted $1.32 EPS. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on HSIC shares. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the stock from $69.00 to $84.00 in a research note on Monday. Finally, Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $79.40.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.